Concepedia

Yan Xia

YX

Statistics

Publications

17

Citations

707

H-Index

14

Active since

2000

Affiliations

Guangzhou University of Chinese Medicine(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Guangdong Provincial Hospital of Traditional Chinese Medicine

China Pharmaceutical University

Tasly Holding Group (China)

Yan Xia is an author at Guangzhou University of Chinese Medicine specializing in pharmacology, medicinal chemistry, and medicine.

ORCID

Publications per year

2000–2020

17

Publications

17

Discovery of a Novel, Orally Active Himbacine-Based Thrombin Receptor Antagonist (SCH 530348) with Potent Antiplatelet Activity

Samuel Chackalamannil, Yuguang Wang, William J. Greenlee et al. · Journal of Medicinal Chemistry · 2008 · 268 citations · Full text

, , +16

Discovery of Potent Orally Active Thrombin Receptor (Protease Activated Receptor 1) Antagonists as Novel Antithrombotic Agents

Samuel Chackalamannil, Yan Xia, William J. Greenlee et al. · Journal of Medicinal Chemistry · 2005 · 124 citations · Full text

, , +17

Design and synthesis of xanthine analogues as potent and selective PDE5 inhibitors

Yuguang Wang, Samuel Chackalamannil, Zhiyong Hu et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 36 citations · Full text

, , +13

The Baltimore Partnership to Educate and Achieve Control of Hypertension (The BPTEACH Trial): A Randomized Trial of the Effect of Education on Improving Blood Pressure Control in a Largely African American Population

Wallace Johnson, Fadia T. Shaya, Niharika Khanna et al. · Journal of Clinical Hypertension · 2011 · 34 citations · Full text

, , +17

Compatibility of Tanshinone IIA and Astragaloside IV in attenuating hypoxia-induced cardiomyocytes injury

Dawei Wang, Yuntao Liu, Guofu Zhong et al. · Journal of Ethnopharmacology · 2017 · 29 citations

, , +15

1–5 of 17